nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

Title
nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis
Authors
Keywords
<em class=EmphasisTypeItalic >nab</em>-Paclitaxel, Visceral disease, Metastatic breast cancer, Taxanes
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 138, Issue 3, Pages 829-837
Publisher
Springer Nature
Online
2013-04-05
DOI
10.1007/s10549-013-2447-8

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started